Updates to our Terms of Use

We are updating our Terms of Use. Please carefully review the updated Terms before proceeding to our website.

Tuesday, April 23, 2024 | Back issues
Courthouse News Service Courthouse News Service

Pharmaceuticals

REDWOOD CITY, Calif. - Directors of Geron Corp. failed to disclose bad side effects of its sole product, a cancer drug, and the stock price fell from $4.40 to $1.69 when the news came out, shareholders claim in San Mateo County Court.

Categories / Uncategorized

Subscribe to Closing Arguments

Sign up for new weekly newsletter Closing Arguments to get the latest about ongoing trials, major litigation and hot cases and rulings in courthouses around the U.S. and the world.

Loading...